This statistic shows the number of active biopharmaceutical ingredients in the development pipeline in Germany as of 2022, by field of indication. 158 active ingredients for oncology were in the first phase of development.
Number of active biopharmaceutical ingredients in development in Germany as of 2022, by field of indication
Characteristic
Phase I
Phase II
Phase III
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Phase l/ lla included in Phase I; active substances in the authorization procedure contained in Phase II; active ingredients in most studies carried out by operating in German companies. * Biotechnologically and genetically engineered ** U. a. Antianaemic, Antithrimbotika, fibrinolytic etc., exclusive hematological oncology *** Eye and ear diseases **** Among other substances for treating muscle, bone, cardiovascular etc. diseases.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
vfa. (July 1, 2023). Number of active biopharmaceutical ingredients in development in Germany as of 2022, by field of indication [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/579956/biopharmaceutical-development-germany-by-indication-field/
vfa. "Number of active biopharmaceutical ingredients in development in Germany as of 2022, by field of indication." Chart. July 1, 2023. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/579956/biopharmaceutical-development-germany-by-indication-field/
vfa. (2023). Number of active biopharmaceutical ingredients in development in Germany as of 2022, by field of indication. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/579956/biopharmaceutical-development-germany-by-indication-field/
vfa. "Number of Active Biopharmaceutical Ingredients in Development in Germany as of 2022, by Field of Indication." Statista, Statista Inc., 1 Jul 2023, https://www.statista.com/statistics/579956/biopharmaceutical-development-germany-by-indication-field/
vfa, Number of active biopharmaceutical ingredients in development in Germany as of 2022, by field of indication Statista, https://www.statista.com/statistics/579956/biopharmaceutical-development-germany-by-indication-field/ (last visited July 22, 2024)
Number of active biopharmaceutical ingredients in development in Germany as of 2022, by field of indication [Graph], vfa, July 1, 2023. [Online]. Available: https://www.statista.com/statistics/579956/biopharmaceutical-development-germany-by-indication-field/
